Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-11 Sale |
2025-02-12 4:50 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
310 | $459.83 | $142,547 | 64,021 (Direct) |
View |
| 2025-02-11 Sale |
2025-02-12 4:36 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer |
3,433 | $459.87 | $1,578,734 | 16,330 (Direct) |
View |
| 2025-02-11 Sale |
2025-02-12 4:29 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
1,747 | $459.83 | $803,323 | 23,225 (Direct) |
View |
| 2025-02-11 Sale |
2025-02-12 4:24 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
1,376 | $459.83 | $632,726 | 9,953 (Direct) |
View |
| 2024-11-15 Sale |
2024-11-19 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
15 | $478.56 | $7,178 | 25,813 (Direct) |
View |
| 2024-11-11 Sale |
2024-11-13 4:15 pm |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
3,000 | $518.27 | $1,554,810 | 44,137 (Direct) |
View |
| 2024-11-08 Sale |
2024-11-12 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
15,198 | $515 | $7,826,970 | 75,772 (Direct) |
View |
| 2024-10-02 Sale |
2024-10-03 4:12 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer |
999 | $461.66 | $461,198 | 16,651 (Direct) |
View |
| 2024-08-30 Sale |
2024-09-04 4:13 pm |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
3,784 | $499 | $1,888,216 | 10,434 (Indirect Direct) |
View |
| 2024-08-30 Sale |
2024-09-04 4:12 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
646 | $500 | $323,000 | 4,435 (Direct) |
View |
| 2024-08-08 Sale |
2024-08-12 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
1,292 | $466.29 | $602,447 | 5,081 (Direct) |
View |
| 2024-08-07 Sale |
2024-08-08 4:06 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
2,280 | $476.75 | $1,086,990 | 23,259 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-13 Tax Withholding |
2025-02-14 4:17 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
2,525 | $450.83 | 30,532 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:17 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
7,209 | $0 | 30,532 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:14 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
6,211 | $0 | 77,684 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:13 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
19,015 | $0 | 135,933 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:11 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
5,546 | $0 | 42,853 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:10 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer |
4,437 | $0 | 20,767 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
6,211 | $0 | 29,436 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
7,903 | $0 | 77,586 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:04 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
2,080 | $0 | 12,033 (Direct) |
View |
| 2025-02-12 Option Award |
2025-02-14 4:03 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
5,324 | $0 | 48,423 (Direct) |
View |
| 2025-02-10 Tax Withholding |
2025-02-12 4:52 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
2,649 | $467.98 | 58,879 (Direct) |
View |
| 2025-02-10 Tax Withholding |
2025-02-12 4:50 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
2,143 | $467.98 | 64,021 (Direct) |
View |
| 2025-02-10 Tax Withholding |
2025-02-12 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
2,056 | $467.98 | 71,473 (Direct) |
View |
| 2025-02-10 Tax Withholding |
2025-02-12 4:46 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
8,300 | $467.98 | 116,918 (Direct) |
View |
| 2025-02-10 Tax Withholding |
2025-02-12 4:38 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
2,142 | $467.98 | 37,307 (Direct) |
View |
| 2025-02-10 Tax Withholding |
2025-02-12 4:36 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer |
1,632 | $467.98 | 16,330 (Direct) |
View |
| 2025-02-10 Tax Withholding |
2025-02-12 4:29 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
876 | $467.98 | 23,225 (Direct) |
View |
| 2025-02-10 Tax Withholding |
2025-02-12 4:26 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
3,220 | $467.98 | 69,683 (Direct) |
View |
| 2025-02-10 Tax Withholding |
2025-02-12 4:24 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
591 | $467.98 | 9,953 (Direct) |
View |
| 2025-02-10 Tax Withholding |
2025-02-12 4:21 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
2,142 | $467.98 | 43,099 (Direct) |
View |
| 2025-02-04 Option Award |
2025-02-06 4:45 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
17,376 | $0 | 61,528 (Direct) |
View |
| 2025-02-04 Option Award |
2025-02-06 4:43 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. |
17,376 | $0 | 66,474 (Direct) |
View |
| 2025-02-04 Option Award |
2025-02-06 4:41 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off |
15,324 | $0 | 73,529 (Direct) |
View |
| 2025-02-04 Option Award |
2025-02-06 4:38 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
15,414 | $0 | 25,848 (Direct) |
View |
| 2025-02-04 Option Award |
2025-02-06 4:37 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
49,446 | $0 | 125,218 (Direct) |
View |
| 2025-02-04 Option Award |
2025-02-06 4:35 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
16,190 | $0 | 39,449 (Direct) |
View |
| 2025-02-04 Option Award |
2025-02-06 4:32 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer |
4,744 | $0 | 21,395 (Direct) |
View |
| 2025-02-04 Option Award |
2025-02-06 4:21 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. |
9,876 | $0 | 25,848 (Direct) |
View |
| 2025-02-04 Option Award |
2025-02-06 4:18 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
23,072 | $0 | 72,903 (Direct) |
View |
| 2025-02-04 Option Award |
2025-02-06 4:15 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
4,420 | $0 | 11,920 (Direct) |
View |
| 2025-02-04 Option Award |
2025-02-06 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer |
19,428 | $0 | 45,241 (Direct) |
View |
| 2025-01-15 Option Award |
2025-01-17 4:04 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
112 | $420.31 | 15,145 (Direct) |
View |
| 2024-10-15 Option Award |
2024-10-17 4:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
90 | $484.39 | 15,033 (Direct) |
View |
| 2024-10-01 Tax Withholding |
2024-10-03 4:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer |
630 | $466.84 | 16,651 (Direct) |
View |
| 2024-08-30 Exercise |
2024-09-04 4:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
646 | $152.74 | 4,435 (Direct) |
View |
| 2024-08-30 Exercise |
2024-09-04 4:12 pm |
N/A 2028-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
646 | $0 | 4,435 (Direct) |
View |
| 2024-08-08 Exercise |
2024-08-12 4:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
1,292 | $152.74 | 5,081 (Direct) |
View |
| 2024-08-08 Exercise |
2024-08-12 4:08 pm |
N/A 2028-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
1,292 | $0 | 5,081 (Direct) |
View |